Novo Nordisk News and Biopharmaceuticals & Diabetes Care Innovation Updates
40.3
0.00
0.00 %
At close
11/06
USD
Daily range
39.53
40.55
40.55
Weekly range
39.53
43.09
43.09
Novo Nordisk stock falls as weak momentum drives price closer to $38.66 support
Novo Nordisk (NVO) stock is trading at $40.25, down 4.58% for the day and near its session low, following a gap lower of $1.02. The stock has fallen below its recent ...
NVO slides over 3% as higher guidance and demand for obesity drugs fail to offset selling pressure
Novo Nordisk A/S (NVO) fell 3.37% after reporting stronger-than-expected third-quarter earnings and an upward revision in its 2026 outlook. The move is limited, as the stock remains below its ...
NVO rises as upward price move continues
Novo Nordisk (NVO) stock is trading at $42.17, rising 4.93% on the day. The price currently sits above its short- and medium-term moving averages while remaining below ...
Novo Nordisk stock rises over 5% as strong Q3 results and robust GLP-1 drug demand boost outlook
Novo Nordisk A/S (NVO) surged 5.32% after the company delivered strong third-quarter results and raised its full-year outlook, fueled by robust demand for its GLP-1 drugs and expanding sales of ...
Novo raises outlook as Wegovy pill drives third-quarter sales growth
Novo is lifting its full-year guidance again after stronger demand for its obesity treatments supports third-quarter revenue and profit. The upgrade gives the Danish drugmaker fresh momentum in ...
Novo Nordisk stock consolidates near $39.72 support amid mixed earnings and buyer support
Novo Nordisk (NVO) stock is trading at $40.24, posting a modest decline on the day. The price sits below its key short- and long-term moving averages, while holding ...
Novo Nordisk draws attention ahead of earnings: NVO gains momentum
Novo Nordisk (NVO) stock is trading at $40.46, up 1.15% on the day and positioned above its key short-term moving averages, signaling strong near-term momentum while ...
NVO climbs as buyer support underpins upward price move
Novo Nordisk (NVO) stock is trading at $40, rising 2.18% for the day. The price stands above its short- and medium-term moving averages, showing a positive intraday ...
What's behind Novo Nordisk's latest stock surge?
Novo Nordisk A/S (NVO) surged 2.03% after investors responded to the FDA approval of its Awiqli pediatric insulin and the latest progress in its ongoing share buyback program. The advance looks ...
NVO advances as buyers drive price higher ahead of earnings event
Novo Nordisk (NVO) stock is trading at $39.15, up 2.25% on the day. The price sits above its short- and medium-term moving averages, indicating a firm underlying trend ...
Why is Novo Nordisk stock up 2.1% today?
Novo Nordisk A/S (NVO) advanced 2.12% as investors responded to ongoing share buybacks and recent FDA approval for its pediatric insulin product, with anticipation building ahead of the upcoming ...
Novo Nordisk shares technical analysis: Consolidation below $38.6 resistance with bearish momentum
Novo Nordisk (NVO) stock is trading at $38.29 after recording a modest decline for the day. The current price sits below its key moving averages, reflecting ongoing ...
Court decision leaves Novo Nordisk stock price vulnerable as sellers dominate
Novo Nordisk (NVO) stock is trading at $38.67, marking a decline of 1.19% for the session. The price remains below its key moving averages, reflecting ongoing negative ...
Will NVO break higher as buyer support offsets competitive headwinds?
Novo Nordisk (NVO) stock is trading at $39.13, closing the day with a modest gain and finishing near the session high. The price remains in a narrow range and currently ...
FDA proposal weighs on Novo Nordisk stock as downward price move persists
Novo Nordisk (NVO) stock is trading at $39.03 after declining 1.03% on the day. The price sits below its key moving averages, reflecting continued short-term and ...
Novo Nordisk stock consolidates near recent highs as buyer support steadies the price
Novo Nordisk (NVO) stock is trading at $39.44, marking a 0.97% gain on the day. The price sits above its short- and medium-term moving averages, reflecting positive ...
Will Novo Nordisk stock sustain gains amid Wegovy pill approval and strong trial data?
Novo Nordisk (NVO) stock is trading at $39.35, up 2.42% on the day. The price is positioned above its key short- and medium-term moving averages, reflecting notable ...
What's behind Novo Nordisk's latest 2.1% stock surge?
Novo Nordisk A/S (NVO) jumped 2.13% after investors responded to progress in the company's ongoing share repurchase programme, which has added significant demand. The rebound looks limited, with ...
Novo Nordisk says CagriSema analysis shows stronger weight loss in women
Novo Nordisk is highlighting new subgroup data for its experimental obesity drug CagriSema as it seeks to strengthen its position in the competitive weight-loss market. The analysis shows women in ...
Novo Nordisk shares technical analysis: Tracking seller momentum near $37.68 support
Novo Nordisk (NVO) stock is trading at $38.42, marking a daily loss of 1.03%. The stock sits below its key moving averages, indicating continued near-term ...
Novo Nordisk stock outlook: Sideways movement likely as range holds above immediate support
Novo Nordisk (NVO) stock is trading at $38.82, ending the session down 1.02% and finishing near the day's low. The price currently sits below its short-term averages ...
